CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-09 | Kocak Ron VP, Controller and PAO | Grant or award · Options | +15,000 | 15,000 | ||
| 2024-01-26 | Agah Ramtin Chief Medical Officer | Purchase | +40,983 | 47,460 | ||
| 2024-01-26 | Agah Ramtin Chief Medical Officer | Purchase · Warrants | +40,983 | 40,983 | ||
| 2024-01-26 | Spiegel Robert J. Director | Purchase | +40,983 | 40,983 | ||
| 2024-01-26 | Spiegel Robert J. Director | Purchase · Warrants | +40,983 | 40,983 | ||
| 2024-01-26 | Bagai Shaun Chief Executive Officer | Purchase | +40,983 | 292,540 | ||
| 2024-01-26 | Bagai Shaun Chief Executive Officer | Purchase · Warrants | +40,983 | 40,983 | ||
| 2024-01-26 | Marton Laurence Director | Purchase | +8,196 | 33,634 | ||
| 2024-01-26 | Marton Laurence Director | Purchase · Warrants | +8,196 | 8,196 | ||
| 2024-01-26 | Macfarlane K. Angela Director | Purchase | +40,983 | 40,983 | ||
| 2024-01-26 | Macfarlane K. Angela Director | Purchase · Warrant Shares | +40,983 | 40,983 | ||
| 2024-01-19 | Bagai Shaun Chief Executive Officer | Grant or award · Stock Option | +66,973 | 66,973 | ||
| 2024-01-19 | Bagai Shaun Chief Executive Officer | Grant or award · Stock Option | +250,263 | 250,263 | ||
| 2024-01-19 | Agah Ramtin Chief Medical Officer | Grant or award · Stock Option | +28,424 | 28,424 | ||
| 2024-01-19 | Agah Ramtin Chief Medical Officer | Grant or award · Stock Option | +125,132 | 125,132 | ||
| 2024-01-19 | Nelms Angela Chief Operating Officer | Grant or award · Stock Option | +33,768 | 33,768 | ||
| 2024-01-19 | Nelms Angela Chief Operating Officer | Grant or award · Stock Option | +125,132 | 125,132 | ||
| 2023-10-03 | Nelms Angela Chief Operating Officer | Purchase | +300 | $1.05 | $315 | 300 |
| 2023-10-03 | Nelms Angela Chief Operating Officer | Purchase | +800 | $1.05 | $836 | 1,100 |
| 2023-10-01 | Spiegel Robert J. Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 |
Page 4 of 6 · 120 trades